← Leaderboards
Robert Harper
Analytical Diagnostic Solutions, Inc.
$9,026,709
Attributed
$9,026,709
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,026,709 · 11
By mechanism
R44$4,300,289 · 3
SB1$2,893,164 · 1
R43$1,833,256 · 7
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Point Of Care”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Mark Marino · Venturewell$61,796,923
- Bala Raja · Luminostics, Inc.$28,624,460
- Hanjoon Ryu$28,519,898
- Scott Fry$21,470,000
- Wally Narajowski$21,300,000
Research focus
Point Of CareBloodDevicesFingersMeterCost EffectiveSamplingMonitorValidationGuidelinesReagentMembraneInheritedCostDiagnosisTechnologyEnzymesTest StripPlasmaGlucosephosphate Dehydrogenase DeficiencyWhole BloodDiagnosticBlood SpecimenEnsure
Grant awards (15)
A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now$906,002
R44 · FY2025 · HD · contact PI
A point-of-care device for the determination of homocysteine (Hcy), the Hcy Now$305,352
R43 · FY2025 · TR · contact PI
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)$982,381
SB1 · FY2023 · AI · contact PI
ADA2 Diagnostic Platform: Point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease Deaminase2 Deficiency (DADA2)$300,000
R43 · FY2023 · AI · contact PI
A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now$295,923
R43 · FY2023 · HD · contact PI
PKU Now-Connect: An intelligent digital ecosystem to improve health outcomes in Phenylketonuria$291,361
R43 · FY2023 · NS · contact PI
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)$920,583
SB1 · FY2022 · AI · contact PI
A point-of-care device for phenylalanine determination$1,002,084
R44 · FY2021 · GM · contact PI
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)$990,200
SB1 · FY2021 · AI · contact PI
A point-of-care device for phenylalanine determination$944,873
R44 · FY2020 · GM · contact PI
A user-friendly point-of-care device for G6PDH determination$574,240
R44 · FY2020 · AI · contact PI
A user-friendly point-of-care device for G6PDH determination$873,090
R44 · FY2019 · AI · contact PI
A point-of-care device for phenylalanine determination$224,700
R43 · FY2018 · GM · contact PI
A point-of-care device for the determination of the Bilirubin, the BiliNow$224,700
R43 · FY2018 · HD · contact PI
A user-friendly point-of-care device for G6PDH determination$191,220
R43 · FY2017 · AI · contact PI